Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02300909 · ClinicalTrials.gov registry record · NA

dHACM in Lumbar Decompression and Microdiscectomy Surgery

A NA study of Spinal Stenosis and Scarring, sponsored by MiMedx Group.

Completed
Registry status
NA
Development phase
143
Enrollment target
1
Study location

NCT02300909: Completed NA study of Spinal Stenosis and Scarring, sponsored by MiMedx Group.

NCT02300909 is a NA study of Spinal Stenosis and Scarring that has completed, run by MiMedx Group. The registered enrollment target is 143 participants, below the 540-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02300909, a NA study of Spinal Stenosis and Scarring, has completed, sponsored by MiMedx Group.

COMPLETED
Registry status
NA
Development phase
143 participants
Enrollment target
1
Study location

Study Summary

Prospective evaluation of the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients as assessed by Oswestry Disability Index.

Primary Outcome

Patient Functional Outcomes Questionnaire

Interventions

  • PROCEDURE Lumbar Decompression Surgery
  • PROCEDURE Microdiscectomy Surgery
  • OTHER Dehydrated Human Amnion/Chorion Membrane (dHACM)

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2014-11
Est. Completion 2018-06
Phase NA
MiMedx Group

32 total trials

What the finished NCT02300909 record still lists

NCT02300909 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 540-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (74% lower).

The record links to 3 conditions, with Spinal Stenosis appearing as the primary indexed condition, and to 3 interventions - of which Lumbar Decompression Surgery is the first listed.

NCT02300909 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02300909 about?

NCT02300909 is a clinical study titled "dHACM in Lumbar Decompression and Microdiscectomy Surgery". Prospective evaluation of the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients as assessed by Oswestry Disability Index.

What is the current status of trial NCT02300909?

This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2014-11. Estimated completion is 2018-06.

What conditions does trial NCT02300909 study?

This clinical trial studies the following conditions: Spinal Stenosis, Scarring, Herniated Disc.

What interventions are being tested in trial NCT02300909?

The interventions under investigation include: Lumbar Decompression Surgery (PROCEDURE), Microdiscectomy Surgery (PROCEDURE), Dehydrated Human Amnion/Chorion Membrane (dHACM) (OTHER).

Who is sponsoring clinical trial NCT02300909?

This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02300909 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02300909's enrollment target sits among peer trials

143 7th of 15 higher than 9 of 15 other Spinal Stenosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02300909, the US trial registry maintained by the National Library of Medicine. NCT02300909 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.